Pasar al contenido principal

ACEITE DE OLIVA VIRGEN Y FUNCIONALIDAD DE LA HDL: UN MODELO DE PREPARACION ESPECIALIZADA DE UN ALIMENTO FUNCIONAL

BES-2010-040766

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Formación de Recursos Humanos de Investigación
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Contratos Predoctorales
Año convocatoria 2010
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Formación e Incorporación de Investigadores
Centro beneficiario FUNDACIO INSTITUT HOSPITAL DEL MAR D'INVESTIGACIONS MEDIQUES
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Impact of virgin olive oil and phenol-enriched virgin olive oils on the HDL Proteome in hypercholesterolemic subjects: a double blind, randomized, controlled, cross-over clinical trial (VOHF Study).

  • Pedret, Anna
  • Catalán, Úrsula
  • Fernández-Castillejo, Sara
  • Farràs Mañé, Marta
  • Valls, Rosa M.
  • Rubió, Laura
  • Canela, Núria
  • Aragonés, Gerard
  • Romeu, Marta
  • Castañer, Olga
  • Torre Fornell, Rafael de la
  • Covas Planells, Maria Isabel
  • Fitó Colomer, Montserrat
  • Motilva, Maria-José
  • Solà, Rosa
The effects of olive oil phenolic compounds (PCs) on HDL proteome, with respect to new aspects of cardioprotective properties, are still unknown. The aim of this study was to assess the impact on the HDL protein cargo of the intake of virgin olive oil (VOO) and two functional VOOs, enriched with their own PCs (FVOO) or complemented with thyme PCs (FVOOT), in hypercholesterolemic subjects. Eligible volunteers were recruited from the IMIM-Hospital del Mar Medical Research Institute (Spain) from April 2012 to September 2012. Thirty-three hypercholesterolemic participants (total cholesterol >200 mg/dL; 19 men and 14 women; aged 35 to 80 years) were randomized in the double-blind, controlled, cross-over VOHF clinical trial. The subjects received for 3 weeks 25 mL/day of: VOO, FVOO, or FVOOT. Using a quantitative proteomics approach, 127 HDL-associated proteins were identified. Among these, 15 were commonly differently expressed after the three VOO interventions compared to baseline, with specific changes observed for each intervention. The 15 common proteins were mainly involved in the following pathways: LXR/RXR activation, acute phase response, and atherosclerosis. The three VOOs were well tolerated by all participants. Consumption of VOO, or phenol-enriched VOOs, has an impact on the HDL proteome in a cardioprotective mode by up-regulating proteins related to cholesterol homeostasis, protection against oxidation and blood coagulation while down-regulating proteins implicated in acute-phase response, lipid transport, and immune response. The common observed protein expression modifications after the three VOOs indicate a major matrix effect. TRIAL REGISTRATION: International Standard Randomized Controlled Trials ISRCTN77500181., This study was supported by: the Ministerio de Economia y Competitividad (AGL2012-40144-C03-02; AGL2012-40144-C03-01 and AGL2012-40144-C03-03 projects and, AGL2009-13517-C03-01 and AGL2009-13517-C03-03 project), CIBEROBN,/nFPI fellowship (BES-2010-040766), ISCIII and Departament de Salut joint contract (CP06/00100)./nAP is a post-graduate research student supported by the Universitat Rovira i Virgili and the Centre/nTecnològic de Nutrició i Salut (CTNS).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Complementary phenol-enriched olive oil improves HDL characteristics in hypercholesterolemic subjects. A randomized, double-blind, crossover, controlled trial. The VOHF study

  • Farràs Mañé, Marta
  • Castañer, Olga
  • Martín-Peláez, Sandra
  • Hernáez, Álvaro
  • Schröder, Helmut, 1958-
  • Subirana Cachinero, Isaac
  • Muñoz Aguayo, Daniel
  • Gaixas, Sònia
  • Torre Fornell, Rafael de la
  • Farré Albaladejo, Magí
  • Rubió, Laura
  • Díaz, Oscar
  • Fernández-Castillejo, Sara
  • Solà, Rosa
  • Motilva, Maria-José
  • Fitó Colomer, Montserrat
Scope: Consumption of olive oil (OO) phenolic compounds (PCs) has beneficial effects on lipid profile. HDL functionality is currently considered to be a more important issue than its circulating quantity. Our aim was to assess whether functional virgin olive oils (FVOOs), one enriched with its own PC (500 ppm; FVOO) and another with OOPC (250 ppm) plus additional complementary PCs from thyme (250 ppm) (total: 500 ppm; FVOOT (functional virgin olive oil with thyme)), could improve HDL functionality related properties versus a virgin OO control (80 ppm; VOO). Methods and results: In a randomized, double-blind, crossover, controlled trial, 33 hypercholesterolemic volunteers received 25 mL/day of VOO, FVOO, and FVOOT during 3 wk. HDL cholesterol increased 5.74% (p < 0.05) versus its baseline after the FVOOT consumption in the participants without hypolipidemic medication. We detected, after FVOOT consumption, an increase in HDL2 -subclass (34.45, SD = 6.38) versus VOO intake (32.73, SD = 6.71). An increment in esterified cholesterol/free cholesterol and phospholipids/free cholesterol in HDL was observed after FVOOT consumption (1.73, SD = 0.56; 5.44, SD = 1.39) compared with VOO intervention (1.53, SD = 0.35; 4.97, SD = 0.81) and FVOO intervention (1.50, SD = 0.33; 4.97, SD = 0.81). Accordingly, lecithin-cholesterol acyltransferase mass increased after FVOOT consumption (1228 μg/mL, SD = 130), compared with VOO consumption (1160 μg/mL, SD = 144). An improvement in HDL oxidative-status was reflected after FVOOT consumption versus its baseline, given an increment in the paraoxonase activity (118 × 10(3) U/L, SD = 24). Conclusion: FVOOT improves HDL-subclass distribution and composition, and metabolism/antioxidant enzyme activities. FVOOT could be a useful dietary tool in the management of high cardiovascular risk patients., This work has been done in the context of Universitat Autònoma de Barcelona (UAB) PhD Program in Biochemistry, Molecular Biology and Biomedicine, Department of Biochemistry and Molecular Biology. We thank Borges Mediterranean Group for providing the common OO used in the study. It was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) financing the project AGL2009-13517-C03-01, AGL2009-13517-C03-02, AGL2009-13517-C03-03, and the FPI-fellowship (BES-2010-040766), by a contract from the Catalan Government and the ISCIII-FEDER (FIS-CP06/00100), by a Sara Borrell contract (CD10/00224), and by grants from ISCIII FEDER (CB06/03/0028), and AGAUR (2014SGR240). CIBEROBN, CIBERESP, and CIBERDEM are initiatives of ISCIII.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Impact of virgin olive oil and phenol-enriched virgin olive oils on the HDL Proteome in hypercholesterolemic subjects: a double blind, randomized, controlled, cross-over clinical trial (VOHF Study).

  • Pedret, Anna
  • Catalán, Úrsula
  • Fernández-Castillejo, Sara
  • Farràs Mañé, Marta
  • Valls, Rosa M.
  • Rubió, Laura
  • Canela, Núria
  • Aragonés, Gerard
  • Romeu, Marta
  • Castañer, Olga
  • Torre Fornell, Rafael de la
  • Covas Planells, Maria Isabel
  • Fitó Colomer, Montserrat
  • Motilva, Maria-José
  • Solà, Rosa
The effects of olive oil phenolic compounds (PCs) on HDL proteome, with respect to new aspects of cardioprotective properties, are still unknown. The aim of this study was to assess the impact on the HDL protein cargo of the intake of virgin olive oil (VOO) and two functional VOOs, enriched with their own PCs (FVOO) or complemented with thyme PCs (FVOOT), in hypercholesterolemic subjects. Eligible volunteers were recruited from the IMIM-Hospital del Mar Medical Research Institute (Spain) from April 2012 to September 2012. Thirty-three hypercholesterolemic participants (total cholesterol >200 mg/dL; 19 men and 14 women; aged 35 to 80 years) were randomized in the double-blind, controlled, cross-over VOHF clinical trial. The subjects received for 3 weeks 25 mL/day of: VOO, FVOO, or FVOOT. Using a quantitative proteomics approach, 127 HDL-associated proteins were identified. Among these, 15 were commonly differently expressed after the three VOO interventions compared to baseline, with specific changes observed for each intervention. The 15 common proteins were mainly involved in the following pathways: LXR/RXR activation, acute phase response, and atherosclerosis. The three VOOs were well tolerated by all participants. Consumption of VOO, or phenol-enriched VOOs, has an impact on the HDL proteome in a cardioprotective mode by up-regulating proteins related to cholesterol homeostasis, protection against oxidation and blood coagulation while down-regulating proteins implicated in acute-phase response, lipid transport, and immune response. The common observed protein expression modifications after the three VOOs indicate a major matrix effect. TRIAL REGISTRATION: International Standard Randomized Controlled Trials ISRCTN77500181., This study was supported by: the Ministerio de Economia y Competitividad (AGL2012-40144-C03-02; AGL2012-40144-C03-01 and AGL2012-40144-C03-03 projects and, AGL2009-13517-C03-01 and AGL2009-13517-C03-03 project), CIBEROBN,/nFPI fellowship (BES-2010-040766), ISCIII and Departament de Salut joint contract (CP06/00100)./nAP is a post-graduate research student supported by the Universitat Rovira i Virgili and the Centre/nTecnològic de Nutrició i Salut (CTNS).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Complementary phenol-enriched olive oil improves HDL characteristics in hypercholesterolemic subjects. A randomized, double-blind, crossover, controlled trial. The VOHF study

  • Farràs Mañé, Marta
  • Castañer, Olga
  • Martín-Peláez, Sandra
  • Hernáez, Álvaro
  • Schröder, Helmut, 1958-
  • Subirana Cachinero, Isaac
  • Muñoz Aguayo, Daniel
  • Gaixas, Sònia
  • Torre Fornell, Rafael de la
  • Farré Albaladejo, Magí
  • Rubió, Laura
  • Díaz, Oscar
  • Fernández-Castillejo, Sara
  • Solà, Rosa
  • Motilva, Maria-José
  • Fitó Colomer, Montserrat
Scope: Consumption of olive oil (OO) phenolic compounds (PCs) has beneficial effects on lipid profile. HDL functionality is currently considered to be a more important issue than its circulating quantity. Our aim was to assess whether functional virgin olive oils (FVOOs), one enriched with its own PC (500 ppm; FVOO) and another with OOPC (250 ppm) plus additional complementary PCs from thyme (250 ppm) (total: 500 ppm; FVOOT (functional virgin olive oil with thyme)), could improve HDL functionality related properties versus a virgin OO control (80 ppm; VOO). Methods and results: In a randomized, double-blind, crossover, controlled trial, 33 hypercholesterolemic volunteers received 25 mL/day of VOO, FVOO, and FVOOT during 3 wk. HDL cholesterol increased 5.74% (p < 0.05) versus its baseline after the FVOOT consumption in the participants without hypolipidemic medication. We detected, after FVOOT consumption, an increase in HDL2 -subclass (34.45, SD = 6.38) versus VOO intake (32.73, SD = 6.71). An increment in esterified cholesterol/free cholesterol and phospholipids/free cholesterol in HDL was observed after FVOOT consumption (1.73, SD = 0.56; 5.44, SD = 1.39) compared with VOO intervention (1.53, SD = 0.35; 4.97, SD = 0.81) and FVOO intervention (1.50, SD = 0.33; 4.97, SD = 0.81). Accordingly, lecithin-cholesterol acyltransferase mass increased after FVOOT consumption (1228 μg/mL, SD = 130), compared with VOO consumption (1160 μg/mL, SD = 144). An improvement in HDL oxidative-status was reflected after FVOOT consumption versus its baseline, given an increment in the paraoxonase activity (118 × 10(3) U/L, SD = 24). Conclusion: FVOOT improves HDL-subclass distribution and composition, and metabolism/antioxidant enzyme activities. FVOOT could be a useful dietary tool in the management of high cardiovascular risk patients., This work has been done in the context of Universitat Autònoma de Barcelona (UAB) PhD Program in Biochemistry, Molecular Biology and Biomedicine, Department of Biochemistry and Molecular Biology. We thank Borges Mediterranean Group for providing the common OO used in the study. It was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) financing the project AGL2009-13517-C03-01, AGL2009-13517-C03-02, AGL2009-13517-C03-03, and the FPI-fellowship (BES-2010-040766), by a contract from the Catalan Government and the ISCIII-FEDER (FIS-CP06/00100), by a Sara Borrell contract (CD10/00224), and by grants from ISCIII FEDER (CB06/03/0028), and AGAUR (2014SGR240). CIBEROBN, CIBERESP, and CIBERDEM are initiatives of ISCIII.